---
title: 4basebio vs eXmoor Pharma
slug_a: 4basebio
slug_b: exmoorpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/4basebio/exmoorpharma
generated_by: BioBM Editorial AI
---

# 4basebio vs eXmoor Pharma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

4basebio (4basebio) is listed for cdmo. 4basebio manufactures high-quality synthetic DNA and RNA using proprietary cell-free amplification technology, supporting mRNA vaccines, viral vectors, gene editing, and cell/gene therapies from research through GMP-grade clinical production.

Services: 7. Modalities: 3. Indications: 0. Locations: 3. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

eXmoor Pharma (exmoorpharma) is listed for cdmo. Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.